UrjansMed: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
UrjansMed
Largest movements
- Cash +€80,244
up €80,244 (+1190.2%), from €6,742 to €86,986
mainly Net result for the year (+€68,208) and Tax, wage and social debts (+€19,483)
- Tangible fixed assets +€2,473
new in 2025: €2,473
- Profit (loss) carried forward +€65,351
up €65,351 (+457.5%), from €14,285 to €79,636
- Tax, wage and social debts +€19,483
up €19,483 (+432.7%), from €4,502 to €23,986
- Other debts -€2,710
down €2,710 (-89.7%), from €3,023 to €313
- Gross operating margin +€67,040
up €67,040 (+316.8%), from €21,160 to €88,200
- Taxes +€14,335
up €14,335 (+303.6%), from €4,721 to €19,056
- Financial charges -€1,117
down €1,117 (-88.0%), from €1,269 to €152
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €24,509 | €107,277 | +€82,768 | +337.7% |
| Fixed assets | 21/28 | - | €2,473 | +€2,473 | |
| Tangible fixed assets | 22/27 | - | €2,473 | +€2,473 | |
| Furniture and vehicles | 24 | - | €2,473 | +€2,473 | |
| Current assets | 29/58 | €24,509 | €104,804 | +€80,295 | +327.6% |
| Amounts receivable within one year | 40/41 | €472 | €0 | -€472 | -100.0% |
| Trade receivables | 40 | €472 | €0 | -€472 | -100.0% |
| Cash at bank and in hand | 54/58 | €6,742 | €86,986 | +€80,244 | +1190.2% |
| Deferred charges and accrued income | 490/1 | €17,295 | €17,818 | +€523 | +3.0% |
| Total equity and liabilities | 10/49 | €24,509 | €107,277 | +€82,768 | +337.7% |
| Equity | 10/15 | €16,285 | €81,636 | +€65,351 | +401.3% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €14,285 | €79,636 | +€65,351 | +457.5% |
| Amounts payable | 17/49 | €8,224 | €25,641 | +€17,417 | +211.8% |
| Amounts payable within one year | 42/48 | €8,224 | €25,641 | +€17,417 | +211.8% |
| Trade debts | 44 | €699 | €1,343 | +€644 | +92.2% |
| Suppliers | 440/4 | €699 | €1,343 | +€644 | +92.2% |
| Taxes, remuneration and social security | 45 | €4,502 | €23,986 | +€19,483 | +432.7% |
| Taxes | 450/3 | €4,502 | €23,986 | +€19,483 | +432.7% |
| Other amounts payable | 47/48 | €3,023 | €313 | -€2,710 | -89.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €304 | +€304 | |
| Other operating charges | 640/8 | €885 | €352 | -€534 | -60.3% |
| Non-recurring operating charges | 66A | - | €129 | +€129 | |
| Gross operating margin | 9900 | €21,160 | €88,200 | +€67,040 | +316.8% |
| Operating profit (loss) | 9901 | €20,275 | €87,416 | +€67,140 | +331.1% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €1,269 | €152 | -€1,117 | -88.0% |
| Recurring financial charges | 65 | €1,269 | €152 | -€1,117 | -88.0% |
| Profit (loss) for the period before taxes | 9903 | €19,006 | €87,264 | +€68,258 | +359.1% |
| Income taxes | 67/77 | €4,721 | €19,056 | +€14,335 | +303.6% |
| Profit (loss) for the period | 9904 | €14,285 | €68,208 | +€53,923 | +377.5% |
| Profit (loss) for the period to be appropriated | 9905 | €14,285 | €68,208 | +€53,923 | +377.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.